In a recent ruling, the Federal Circuit made a key determination on an important matter of precedent regarding obviousness-type double patenting (ODP). The court ruled that ODP is applicable to patent claims that claim priority to the same application but have differing expiration dates due solely to patent term adjustment (PTA). The judgment came in the case, Cellect v. MoFo Life Sciences.
This decision signals a potential shift in patent narratives and could have wide-reaching implications for the patent landscape. Patent holders claiming priority to the same application, who have been able to get extended patent terms due to PTA, could potentially face challenges.
PTA is a mechanism that allows for the extension of the term of a U.S. patent. It provides patent owners another route to extend the life of their patents beyond the standard term, particularly when the U.S. Patent and Trademark Office (USPTO) fails to meet certain examination timelines. The Federal Circuit’s decision now raises questions about such extensions in the context of ODP.
For legal professionals working in large corporations and law firms, especially those dealing with patent law, understanding the impact of this ruling will be crucial. Potential litigation might arise, as other patent holders with similar situations may come under scrutiny. Additionally, it begs the question of how the USPTO will handle future PTAs with respect to ODP.
In the grand scheme, this decision might prompt a closer look at patent applications and PTA requests, possibly necessitating more thorough investigations to ensure that ODP rules aren’t violated. As a result, patent professionals and legal practitioners alike should be aware of the potential changes and challenges this precedent-setting ruling may bring.